What does the Cardiovascular-Kidney-Metabolic (CKM) Syndrome mean for nephrologists?
Optimising care and managing complications for the CKD patient
These series’ independent e-seminars are supported by AstraZeneca.
6 / 6 results found
Speaker
James Burton, United Kingdom
Panellists
Andrew Frankel, United Kingdom
Aaron Wong, United Kingdom
Moderator
Smeeta Sinha, United Kingdom
Optimising care and managing complications for the CKD patient
CKD Progression: interpreting guidelines through the lens of recent data; CKD and RAASi optimisation
Speaker
Philip Kalra, United Kingdom
Panellist
Sunil Bhandari, United Kingdom
Moderator
Smeeta Sinha, United Kingdom
Optimising care and managing complications for the CKD patient
Speaker
Carla Avesani, Sweden
Panellists
Deborah Clegg, United States
Kieran Mccafferty, United Kingdom
Moderator
Smeeta Sinha, United Kingdom
Optimising care and managing complications for the CKD patient
Panellists
Shelly Zieroth, Canada
Biff Palmer, USA
Maria Soler, Spain
Moderator
Smeeta Sinha, United Kingdom
Optimising care and managing complications for the CKD patient
Panellists
Lucia Del Vecchio, Italy
David Thomas, United Kingdom
Dimitrios Poulikakos, United Kingdom
Moderator
Smeeta Sinha, United Kingdom
Optimising care and managing complications for the CKD patient
Panellists
Beatriz Fernández Fernández, Spain
Patrick Mark, United Kingdom
Ana Cerebrian, Spain
Janaka Karalliedde, United Kingdom
Moderator
Christoph Wanner, Germany
Optimising care and managing complications for the CKD patient